The European Union (EU) is considering whether to approve the use of a novel coronavirus infection (Corona 19) vaccine developed by Russia.
On the 13th (local time), President Kirill Dmitry of the Russian Direct Investment Fund (RDIF) announced that the EU will begin to look into whether Russia’s Corona 19 vaccine’Sputnik V’is approved on the 19th, Sputnik News Agency reported.
The Russian sovereign wealth fund, RDIF, supported the development. Russia applied for emergency use of Sputnik V to the EU on the 22nd of last month through RDIF.
“The first step toward obtaining approval for emergency use in the EU is scheduled for the 19th,” said Dmitry. There will be a so-called’scientific review’.” Earlier, a spokesman for the EU Commission said that negotiations are underway on the approval of a vaccine in Russia. The EU has repeatedly emphasized that the COVID-19 vaccine must meet EU quality standards to be approved. did.
The EU has approved two vaccines developed by US pharmaceutical companies Pfizer and German Bioentech and US pharmaceutical company Modena. At the end of this month, it will decide whether to approve a vaccine developed by Oxford University in the UK and AstraZeneca, a multinational pharmaceutical company.
Russia approved Sputnik V as the world’s first COVID-19 vaccine in August last year. However, due to approval before the final phase 3 clinical trial was completed, controversy about safety and efficacy arose.
In mid-December, the National Institute of Infectious Disease Microbiology in Gamaleya, under the Ministry of Health of Russia, which developed the vaccine, announced that it had a 91.4% preventive effect in the final phase 3 clinical trial.
Western countries such as the United States, however, are not confident in the safety and efficacy of Russian vaccines.
Sputnik V has been introduced by Russia, Belarus, Argentina, Algeria, Palestine, Serbia, and Bolivia.
*The article has been translated based on the content of 동아닷컴 : 동아일보 전체 뉴스 by www.donga.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!